Woman's World on MSN1d
My Review of Nestlé’s New Vital Pursuit Frozen Food Line for GLP-1 Users
When it comes to weight loss, we've all been told that eating a healthy, balanced diet holds the key to success. But for many ...
ResMed Stock Is S&P 500’s Worst Performer. GLP-1 Drugs Are a Risk.
Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments
It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...
STAT1d
Long-overlooked scientist shares Lasker Award with other GLP-1 researchers
GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...
What Experts Think About Lemme's New GLP-1 Supplement
The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...
GLP-1 drugs could help prevent 34,000 heart attacks and strokes in the US each year, research suggests
Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...
Convenience Store News1d
GLP-1 Drugs Are Changing the Dynamics of the Shopping Basket
The increasing popularity of these weight loss drugs is likely to shape how individuals approach food choices and meal ...
foodengineeringmag4h
Nestlé Launches Vital Pursuit Brand Targeting GLP-1 Users
The line includes thoughtfully portioned meals that offer at least 20 grams of protein and contain essential nutrients such ...
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...
Medpage Today on MSN4d
GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Death
GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...
Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform committed to breaking down ...